UT Health San Antonio specialists to discuss latest treatments of movement disorders

January 25, 2023

Deep brain stimulation, continuous levodopa infusion among topics Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Jan. 25, 2023) — Four fellowship-trained movement disorders neurologists from UT Health San Antonio will give talks Friday (Jan. 27) at the Parkinson’s Foundation Tri-State Symposium. These physicians will discuss the newest developments in research and clinical trials of Parkinson’s […]




UT Health San Antonio-UTSA team studies compounds aimed at brain cancer

January 24, 2023

Basic science generates new drug for treating glioblastoma, the deadliest cancer Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu Ryan Schoensee, 210-458-6054, ryan.schoensee@utsa.edu SAN ANTONIO (Jan. 24, 2023) — Glioblastoma multiforme (GBM) is an aggressive brain cancer associated with the worst overall survival rates among all human cancers. Only 65% of GBM patients live one year past diagnosis […]

Head x-ray, brain in MRI



Increasing brain protein could be a treatment for obesity

January 20, 2023

  Drug target that revs up energy expenditure, reduces appetite identified Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Jan. 20, 2023) — A drug that promotes energy expenditure in the body while suppressing appetite could be a powerful weight loss therapy. Researchers at The University of Texas Health Science Center at San Antonio, the Second […]




The Center for Brain Health (Opening in 2024-25)

January 19, 2023

Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu With more than 50 studies, departments and centers, the Center for Brain Health at The University of Texas Health Science Center at San Antonio will be home to the institution’s many brain health initiatives. For a complete overview of these vital programs, visit https://advancingbrainhealth.org/. Recently, UT Health San Antonio received […]

Scanning of a human brain by X-rays


A new era in Alzheimer’s treatment

January 11, 2023

Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu Statement from the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio about a timely topic in the news: The U.S. Food and Drug Administration on Friday, Jan. 6, 2023, approved lecanemab, a drug that targets the basic pathophysiology of Alzheimer’s disease. The FDA action is […]

Alzheimer's written in wooden cubes on a table